Neoadjuvant Chemotherapy A New Therapeutic Challenge in Treatment of Ovarian Cancer- A Review

Recent theory FimbriaEndometrial tissue Tubal-mesothelial junctionOvarian cancer is one of the most sensitive of all solid tumors to antineoplastic chemotherapy, and responses are expected in over 80% of women who receive standard platinum and paclitaxel based treatment [7].Despite this fact; the majority of women with advanced ovarian cancer will ultimately relapse and develop drugresistant disease.Treatment of epithelial ovarian cancer is based on the combination of surgery and chemotherapy AbstractAs per literature survey reveals that ovarian cancer is the most lethal gynecologic malignancy in females all over the world.In majority of patients who suffering from ovarian cancer clinical complete remissions are obtained through combinations of cytoreductive surgery and chemotherapy.This review represents an overview of the origin of ovarian cancer, history of chemotherapeutic regimens and also focused on chemotherapeutic agents which are useful in the treatment of ovarian cancer.Taxanes are most promising drug used in neoadjuvant chemotherapy.This review adds better advances in medical field may be based on the better understanding of drugs regimens and better control of cost in routine practice which opens the new doors for neoadjuvant chemotherapy which proves a better option in ovarian cancer treatment.